Anagallis Arvensis 30 [hp_C]/1
Anagallis Arvensis · PELLET · Hahnemann Laboratories, INC.
Anagallis Arvensis is an over-the-counter oral pellet medication available in the United States. This herbal preparation is traditionally used in homeopathic medicine, though its specific clinical uses and effectiveness have not been established through standard clinical trials.
Key Facts
- Brand Name
- Anagallis Arvensis
- Generic Name
- Anagallis Arvensis
- NDC Code (Product)
37662-3666- Manufacturer
- Hahnemann Laboratories, INC.
- Strength
- 30 [hp_C]/1
- Dosage Form
- PELLET
- Route
- ORAL
- Marketing Status
- Marketing Start
- 08/02/2023
Recall History
No Recall HistoryFull Prescribing Information
Frequently Asked Questions
What is Anagallis Arvensis used for?
Anagallis Arvensis is an over-the-counter oral pellet medication available in the United States. This herbal preparation is traditionally used in homeopathic medicine, though its specific clinical uses and effectiveness have not been established through standard clinical trials.
Is Anagallis Arvensis a controlled substance?
Anagallis Arvensis is not classified as a controlled substance by the DEA.
What is the generic name for Anagallis Arvensis?
The generic name for Anagallis Arvensis is Anagallis Arvensis. There are 1 other brand versions of Anagallis Arvensis.
What is the NDC code for Anagallis Arvensis 30 [hp_C]/1?
The NDC (National Drug Code) for Anagallis Arvensis 30 [hp_C]/1 is 37662-3666, listed by Hahnemann Laboratories, INC..
Other Anagallis Arvensis Dosages
- Anagallis Arvensis12 [hp_C]/137662-3665
- Anagallis Arvensis30 [hp_X]/23g53645-2051
- Anagallis Arvensis200 [hp_C]/137662-3668
- Anagallis Arvensis10 [hp_M]/137662-3671
- Anagallis Arvensis200 [kp_C]/200[kp_C]0220-0313
- Anagallis Arvensis500 [hp_C]/137662-3669
- Anagallis Arvensis1 [hp_M]/137662-3670
- Anagallis Arvensis6 [hp_C]/137662-3664
- Anagallis Arvensis100 [hp_C]/137662-3667
Other Anagallis Brands
See all →Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)